Biomarkers for Immunotherapy of Oral Squamous Cell Carcinoma: Current Status and Challenges
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers for Immunotherapy of Oral Squamous Cell Carcinoma: Current Status and Challenges
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-08
DOI
10.3389/fonc.2021.616629
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overall assessment of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: time to take notice
- (2020) Alhadi Almangush et al. ACTA OTO-LARYNGOLOGICA
- The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation
- (2020) Matthew P. Humphries et al. BMC CANCER
- A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer
- (2020) Inger-Heidi Bjerkli et al. VIRCHOWS ARCHIV
- Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma
- (2020) Dovile Zilenaite et al. Frontiers in Oncology
- Stromal categorization in early oral tongue cancer
- (2020) Alhadi Almangush et al. VIRCHOWS ARCHIV
- Immune‐related signature predicts the prognosis and immunotherapy benefit in bladder cancer
- (2020) Yejinpeng Wang et al. Cancer Medicine
- Digital Image Analysis of CD8+ and CD3+ Tumor-Infiltrating Lymphocytes in Tongue Squamous Cell Carcinoma
- (2020) Yenlin Huang et al. Cancer Management and Research
- Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma
- (2020) Jonathan D. Schoenfeld et al. JAMA Oncology
- Biopsy quality is essential for preoperative prognostication in oral tongue cancer
- (2020) Ibrahim O. Bello et al. APMIS
- Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better?
- (2020) John H. Strickler et al. CLINICAL CANCER RESEARCH
- Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer
- (2020) Kenneth Emancipator et al. MODERN PATHOLOGY
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Integrating histopathology, immune biomarkers, and molecular subgroups in solid cancer: the next step in precision oncology
- (2019) Nicolas A. Giraldo et al. VIRCHOWS ARCHIV
- Stromal tumor‑infiltrating lymphocytes evaluated on H&E‑stained slides are an independent prognostic factor in epithelial ovarian cancer and ovarian serous carcinoma
- (2019) Chungsu Hwang et al. Oncology Letters
- Tissue-infiltrating immune cells as prognostic markers in oral squamous cell carcinoma: a systematic review and meta-analysis
- (2019) Elin Hadler-Olsen et al. BRITISH JOURNAL OF CANCER
- Development and validation of a seven‐immune‐feature‐based prognostic score for oral squamous cell carcinoma after curative resection
- (2019) Chen Zhou et al. INTERNATIONAL JOURNAL OF CANCER
- The Prognostic Role of Tumour‐infiltrating Lymphocytes in Oral Squamous Cell Carcinoma: a Meta‐analysis
- (2019) Zhengxian Huang et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Evaluating the prognostic significance of tumor-infiltrating lymphocytes in solid tumor: practice of a standardized method from the International Immuno-Oncology Biomarkers Working Group
- (2019) Jiuyang Liu et al. Cancer Management and Research
- Assessment of Tumor-infiltrating Lymphocytes Using International TILs Working Group (ITWG) System Is a Strong Predictor of Overall Survival in Colorectal Carcinoma
- (2019) Talia L. Fuchs et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- A Novel Digital Score for Abundance of Tumour Infiltrating Lymphocytes Predicts Disease Free Survival in Oral Squamous Cell Carcinoma
- (2019) Muhammad Shaban et al. Scientific Reports
- Immune checkpoint inhibitors win the 2018 Nobel Prize
- (2019) Pei-Wei Huang et al. Biomedical Journal
- Immunotherapy for head and neck cancer: Recent advances and future directions
- (2019) John D. Cramer et al. ORAL ONCOLOGY
- Tumor Immunology and Immunotherapy for Head and Neck Squamous Cell Carcinoma
- (2018) J.M. Moskovitz et al. JOURNAL OF DENTAL RESEARCH
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
- (2018) M Oliva et al. ANNALS OF ONCOLOGY
- The clinical role of the TME in solid cancer
- (2018) Nicolas A. Giraldo et al. BRITISH JOURNAL OF CANCER
- Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy
- (2018) Dan P. Zandberg et al. EUROPEAN JOURNAL OF CANCER
- Deep learning for detecting tumour-infiltrating lymphocytes in testicular germ cell tumours
- (2018) Nina Linder et al. JOURNAL OF CLINICAL PATHOLOGY
- The prognostic value of immune checkpoints in oral squamous cell carcinoma
- (2018) Meri Sieviläinen et al. ORAL DISEASES
- Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
- (2018) Razvan Cristescu et al. SCIENCE
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- The immune contexture in cancer prognosis and treatment
- (2017) Wolf H. Fridman et al. Nature Reviews Clinical Oncology
- Prognostic biomarkers in oral squamous cell carcinoma: A systematic review
- (2017) César Rivera et al. ORAL ONCOLOGY
- Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma Patients
- (2016) E. R. Parra et al. CLINICAL CANCER RESEARCH
- Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma
- (2016) Marlon C. Rebelatto et al. Diagnostic Pathology
- Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort
- (2016) Laura Q.M. Chow et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Big opportunities for small molecules in immuno-oncology
- (2015) Jerry L. Adams et al. NATURE REVIEWS DRUG DISCOVERY
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now